Mangiferin attenuate sepsis-induced acute kidney injury via antioxidant and anti-inammatory effects

American Journal of Nephrology

Volumn 40, Issue 5, 2014, Pages 441-450

  He, Liyu ^a   Peng, Xiaofei ^a   Zhu, Jiefu ^a   Chen, Xian ^a   Liu, Hong ^a   Tang, Chengyuan ^a   Dong, Zheng ^a   Liu, Fuyou ^a   Peng, Youming ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Mangiferin; NLRP3; Nrf2; Sepsis induced acute kidney injury

Indexed keywords

CREATININE; CRYOPYRIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MANGIFERIN; TRANSCRIPTION FACTOR NRF2; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CARRIER PROTEINS; CIAS1 PROTEIN, MOUSE; INFLAMMASOMES; INTERLEUKIN-1; INTERLEUKIN-18; LIPOPOLYSACCHARIDES; NF-E2-RELATED FACTOR 2; NOD-LIKE RECEPTOR 3, RAT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; XANTHONES;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONTROLLED STUDY; EPITHELIUM CELL; KIDNEY EPITHELIUM; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; SEPSIS; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; ANIMALS; COMPLICATION; CYTOLOGY; DRUG EFFECTS; KIDNEY TUBULES, PROXIMAL; METABOLISM; MICE; RATS;

ACUTE KIDNEY INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; CARRIER PROTEINS; INFLAMMASOMES; INTERLEUKIN-1; INTERLEUKIN-18; KIDNEY TUBULES, PROXIMAL; LIPOPOLYSACCHARIDES; MICE; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEPSIS; XANTHONES;

EID: 84912059327     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000369220     Document Type: Article

References (41)

1. Abraham E, Singer M: Mechanisms of sepsisinduced organ dysfunction. Crit Care Med 2007; 35: 2408-2416.
2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 2007; 35: 1244-1250.
3. Zarjou A, Agarwal A: Sepsis and acute kidney injury. J Am Soc Nephrol 2011; 22: 999-1006.
4. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, et al: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294: 813-818.
5. Quoilin C, Mouith ys-Mickalad A, Lecart S, Fontaine-Aupart MP, Hoebeke M: Evidence of oxidative stress and mitochondrial respiratory chain dysfunction in an in vitro model of sepsis-induced kidney injury. Biochim Biophys Acta 2014; 1837: 1790-1800
6. Latz E, Xiao TS, Stutz A: Activation and regulation of the inflammasomes. Nat Rev Immunol 2013; 13: 397-411.
7. Turner CM, Arulkumaran N, Singer M, Unwin RJ, Tam FW: Is the inflammasome a potential therapeutic target in renal disease? BMC Nephrol 2014; 15: 21.
8. Shigeoka AA, Mueller JL, Kambo A, Mathison JC, King AJ, Hall WF, Correia Jda S, Ulevitch RJ, Hoffman HM, McKay DB: An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol 2010; 185: 6277-6285.
9. Bakker PJ, Butter LM, Claessen N, Teske GJ, Sutterwala FS, Florquin S, Leemans JC: A tissue-specific role for Nlrp3 in tubular epithelial repair after renal ischemia/reperfusion. Am J Pathol 2014; 184: 2013-2022.
10. Luo YP, Jiang L, Kang K, Fei DS, Meng XL, Nan CC, Pan SH, Zhao MR, Zhao MY: Hemin inhibits NLRP3 inflammasome activation in sepsis-induced acute lung injury, involving heme oxygenase-1. Int Immunopharmacol 2014; 20: 24-32.
11. Kaspar JW, Niture SK, Jaiswal AK: Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 2009; 47: 1304-1309.
12. Shelton LM, Park BK, Copple IM: Role of Nrf2 in protection against acute kidney injury. Kidney Int 2013; 84: 1090-1095.
13. Ruiz S Pergola PE Zager R.A. Vaziri ND: Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 2013 83 1029-1041.
14. Tsai PY, Ka SM, Chang JM, Lai JH, Dai MS, Jheng HL, Kuo MT, Chen P, Chen A: Antroquinonol differentially modulates T cell activity and reduces interleukin-18 production, but enhances Nrf2 activation, in murine accelerated severe lupus nephritis. Arthritis Rheum 2012; 64: 232-242.
15. Telang M, Dhulap S, Mandhare A, Hirwani R: Therapeutic and cosmetic applications of mangiferin: A patent review. Expert Opin Ther Pat 2013; 23: 1561-1580.
16. Vyas A, Syeda K, Ahmad A, Padhye S, Sarkar FH: Perspectives on medicinal properties of mangiferin. Mini Rev Med Chem 2012; 12: 412-425.
17. Xing X, Li D, Chen D, Zh ou L, Chonan R, Yamahara J, Wang J, Li Y: Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: A link to amelioration of fatty liver. Toxicol Appl Pharmacol 2014; 280: 207-215.
18. Jangra A, Lukhi MM, Sulakhiya K, Baruah CC, Lahkar M: Protective effect of mangiferin against lipopolysaccharide-induced depressive and anxiety-like behaviour in mice. Eur J Pharmacol 2014; 740: 337-345.
19. Jeong JJ, Jang SE, Hyam SR, Han MJ, Kim DH: Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-?B and MAPK pa thways. Eur J Pharmacol 2014; 740: 652-661.
20. Liu YW, Zhu X, Zhang L, Lu Q, Wang JY, Zhang F, Guo H, Yin JL, Yin XX: Up-regulation of glyoxalase 1 by mangiferin prevents dia betic nephropathy progression in streptozotocin-induced diabetic rats. Eur J Pharmacol 2013; 721: 355-364.
21. Ghosh M, Das J, Sil PC: D(+) galactosamine induced oxidative and nitrosative stress-medi ated renal damage in rats via NF-?B and inducible nitric oxide synthase (iNOS) pathways is ameliorated by a polyphenol xanthone, mangiferin. Free Radic Res 2012; 46: 116-132.
22. Dong G, Luo J, Kumar V, Dong Z: Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells. Am J Physiol Renal Physiol 2010; 298:F293-F300.
23. He L, Peng Y, Liu H, Yin W, Chen X, Peng X, Shao J, Liu Y, Liu F: Activation of the interleukin-4/signal transducer and activator of transcription signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy. Am J Nephrol 2013; 38: 321-332.
24. Yasuda H, Yuen PS, Hu X, Zhou H, Star RA: Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int 2006; 69: 1535-1542.
25. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, et al: Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012; 36: 401-414.
26. Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, Kong AN: Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits a poptosis. Biochem Pharmacol 2008; 76: 1485-1489.
27. Martensson J, Bellomo R: The rise and fall of NGAL in acute kidney injury. Blood Purif 2014; 37: 304-310.
28. Dirkes S: Sepsis and inflammation: Impact on acute kidney injury. Nephrol Nurs J 2013; 40: 125-132; quiz 133.
29. Pascual-Guardia S, Arbol F, Sanchez E, Casadevall C, Merlo V, Gea J, Barreiro E: Inflammation and oxidative stress in respiratory and limb muscles of patients with severe sepsis. Med Clin (Barc) 2013; 141: 194-200.
30. Copple IM: The Keap1-Nrf2 cell defense pathway-A promising therapeutic target? Adv Pharmacol 2012; 63: 43-79.
31. Choi BH, Kang KS, Kwak MK: Effect of redox modulating NRF2 activators on chronic kidney disease. Molecules 2014; 19: 12727-12759.
32. Ryoo IG, Ha H, Kwak MK: Inhibitory role of the KEAP1-NRF2 pathway in TGF?1-stimulated renal epithelial transition to fibroblastic cells: A modulatory effect on SMAD signaling. PLoS One 2014; 9:e93265.
33. Wu J, Liu X, Fan J, Chen W, Wang J, Zeng Y, Feng X, Yu X, Yang X: Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway. Toxicology 2014; 318: 22-31.
34. Park EJ, Kim YM, Park SW, Kim HJ, Lee JH, Lee DU, Chang KC: Induction of HO-1 through p38 MAPK/Nrf2 signaling pathway by ethanol extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264.7 cells and CLP-induced septic mice. Food Chem Toxicol 2013; 55: 386-395.
35. Kong X, Thimmulappa R, Craciun F, Harvey C, Singh A, Kombairaju P, Reddy SP, Remick D, Biswal S: Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis. Am J Respir Crit Care Med 2011; 184: 928-938.
36. S utterwala FS, Haasken S, Cassel SL: Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci 2014; 1319: 82-95.
37. Ratsimandresy RA, Dorfleutner A, Stehlik C: An update on PYRIN domain-containing pattern recognition receptors: From immunity to pathology. Front Immunol 2013; 4: 440.
38. Kim SJ, Lee SM: NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced a cute liver failure: Role of heme oxygenase-1. Free Radic Biol Med 2013; 65: 997-1004.
39. Anders HJ, Muruve DA: The inflammasomes in kidney disease. J Am Soc Nephrol 2011; 22: 1007-1018.
40. Chang A, Ko K, Clark MR: The emerging role of the inflammasome in kidney diseases. Curr Opin Nephrol Hypertens 2014; 23: 204-210.
41. Matkowski A, Kus P, Goralska E, Wozniak D: Mangiferin-A bioactive xanthonoid, not only from mango and not just antioxidant. Mini Rev Med Chem 2013; 13: 439-455.